Bladder cancer: Management of NMI and muscle-invasive cancer

Bladder cancer: Management of NMI and muscle-invasive cancer


Link to Full Text

Download Full Text


Bladder cancer is one of the most exciting urological cancers. It exists in two forms - non-muscle-invasive (Nmi) and muscle-invasive (Mi) disease. The difference in the clinical picture has been the focus of significant research in defining the molecular characteristics of urothelial cancer (Uc) of the bladder. This book provides an overview of the most hotly debated areas in bladder cancer. Authors have focused on the emerging role of markers for Nmi Uc and various ways of improving the efficacy of current chemotherapy in the first section. The second section has focused on the surgical aspects of Mi Uc. Two major areas of debate - the role of pelvic lymph node dissection and genital sparing surgery - are discussed in this section.

Table of Contents

1. Intravesical Treatment Modalities in Bladder Cancer: Current and Future Perspectives
2. Intravesical Chemohyperthermia for NMIBC: Rationale and Results of This Developing Treatment
3. Cross-Polarization OCT for In Vivo Diagnostics and Prediction of Bladder Cancer
4. Bladder Cancer Markers and Recent Innovations
5. Lymphadenectomy in Muscle Invasive Bladder Cancer
6. Genital Organs‐Sparing Radical Cystectomy in Female Patients with Muscle Invasive Urothelial Carcinoma of the Bladder

Publication Information





Cancer, urological cancers, urothelial cancer, bladder, chemotherapy

Bladder cancer: Management of NMI and muscle-invasive cancer